Special Issue: Hepatocellular Carcinoma

Published: 2013-11-18

Hepatocellular carcinoma (HCC) ranks among the most common cancers worldwide, and is one of the leading causes of cancer-related death. Worldwide, there are more than 600,000 cases of HCC every year, and the 5 year mortality is nearly 90%. Treatment of HCC is complex, and involves understanding of the cancer as well as the underlying liver disease. This special issue of Translational Cancer Research serves as a review of all issues surrounding diagnosis and treatment of hepatocellular carcinoma.

  • Preface (Guest Editor) 
  • Surgical Resection for Hepatocellular Carcinoma (Amanda Cooper, Tom Aloia, Anderson Cancer Center, USA)
  • Efficacy of Combination Treatment Modalities for Intermediate and Advanced Hepatocellular Carcinoma: Intra-arterial Therapies, Sorafenib and Novel Small Molecules (Robert Gish, University of Nevada, USA)
  • Review on Liver Transplant for Hepatocellular Carcinoma (Catherine Ferenette, Scripps Green Hospital, USA)
  • Hepatocellular Carcinoma: A review of the path(way) forward (Zheng Z. Topp, Scripps Clinic, USA)
  • Stereotactic Body Radiation Therapy in Liver Cancer Treatment (Jona Hattangadi-Gluth and Anthony Paravati, University of California San Diego, USA) 
  • Epidemiology and risk factors for development of hepatocellular carcinoma (Howard P. Monsour, Methodist Hospital, USA)
  • Particle Beam Therapy in Liver Cancer Treatment (Huan Giap, Scripps Proton Therapy Center, USA)